Trials / Recruiting
RecruitingNCT06979037
Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research
Clinical Investigation of Genetic Markers in Diabetic Ulcers and Their Role in Personalized Treatment Targeting
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 712 (estimated)
- Sponsor
- The First Affiliated Hospital of University of South China · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial involves collecting peripheral blood, ulcer tissue, and fecal samples from diabetic ulcer patients for bioinformatics analysis to screen genetic markers significantly associated with ulcer risk and healing differences. Furthermore, multi-omics data will be integrated to establish a diabetic ulcer risk prediction model. Based on key single nucleotide polymorphisms and their regulatory pathways, potential new drug targets for promoting healing will be explored, providing a genetic basis for personalized treatment.
Conditions
Timeline
- Start date
- 2024-05-16
- Primary completion
- 2027-05-16
- Completion
- 2027-05-16
- First posted
- 2025-05-18
- Last updated
- 2025-05-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06979037. Inclusion in this directory is not an endorsement.